Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model (Q42273331)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 August 2013

Language	Label	Description	Also known as
English	Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model	scientific article published on 29 August 2013

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model (English)

1 reference

Europe PubMed Central

19 October 2017

0 references

author name string

Alberto Monroy-García

1

1 reference

Europe PubMed Central

19 October 2017

Miguel Angel Gómez-Lim

2

1 reference

Europe PubMed Central

19 October 2017

Benny Weiss-Steider

3

1 reference

Europe PubMed Central

19 October 2017

Jorge Hernández-Montes

4

1 reference

Europe PubMed Central

19 October 2017

Sara Huerta-Yepez

5

1 reference

Europe PubMed Central

19 October 2017

Jesús F Rangel-Santiago

6

1 reference

Europe PubMed Central

19 October 2017

Edelmiro Santiago-Osorio

7

1 reference

Europe PubMed Central

19 October 2017

María de Lourdes Mora García

8

1 reference

Europe PubMed Central

19 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

29 August 2013

1 reference

Europe PubMed Central

19 October 2017

number of pages

15

1 reference

based on heuristic

inferred from page(s)

Archives of Virology

1 reference

Europe PubMed Central

19 October 2017

159

1 reference

Europe PubMed Central

19 October 2017

291-305

1 reference

Europe PubMed Central

19 October 2017

2

1 reference

Europe PubMed Central

19 October 2017

https://scigraph.springernature.com/pub.10.1007/s00705-013-1819-z

0 references

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Human papillomavirus oncoproteins: pathways to transformation

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Human papillomavirus 16 L1-E7 chimeric virus like particles show prophylactic and therapeutic efficacy in murine model of cervical cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Production of human papillomavirus type 16 virus-like particles in transgenic plants

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Oral immunogenicity of human papillomavirus-like particles expressed in potato

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Neutralizing antibodies against human papillomavirus types 16, 18, 31, 52, and 58 in serum samples from women in Japan with low-grade cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Persistent antibodies to HPV virus-like particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

HPV - immune response to infection and vaccination

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

A review of clinical trials of human papillomavirus prophylactic vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Fc receptor signaling and trafficking: a connection for antigen processing

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Physical interaction of human papillomavirus virus-like particles with immune cells

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1819-Z

21 January 2018

Identifiers

10.1007/S00705-013-1819-Z

1 reference

Europe PubMed Central

19 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42273331&oldid=1940884190"